[ST elevation acute coronary syndromes. Pharmaco-mechanic strategy is the universal treatment future?].
The main objective in the medical treatment of the ST elevation acute myocardial infarction, must have the intention to reperfuse the culprit involved artery. In order to reduce this time, the pharmaco-invasive strategy may offer rapid flow recanalization in the culprit artery and reduce the damage of the myocardium. The new pharmacologic combinations includes half dose of fibrinolytics, alone or in combination with IIb/IIIa inhibitors, this combination may offer advantages of the flow. This concept involves the that PCI (Percutaneous Coronary Interventions), can be done in a subsequent time. The risk of bleeding is increased with this strategy, and some evaluation or bleeding risk must be done in all patients, as in patients with 75 years and older.
Juárez Herrera
Ursulo
U
Servicio de Urgencias y Unidad Coronaria del Instituto Nacional de Cardiología Ignacio ChávezTlalpan , Mexićo. ujuarez@mail.medinet.net.mx
D000208:Acute Disease; D000789:Angina, Unstable / Q000188:drug therapy / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy*; D013577:Syndrome